242138-07-4

URI: https://gptkb.org/entity/242138-07-4
GPTKB entity
Statements (28)
Predicate Object
gptkbp:instanceOf gptkb:chemical_compound
gptkbp:approvedBy gptkb:FDA
gptkbp:ATCCode J02AC11
gptkbp:brand gptkb:Cresemba
gptkbp:CASNumber gptkb:242138-07-4
gptkbp:developedBy gptkb:Basilea_Pharmaceutica
gptkbp:hasInChIKey QGQKQHSAKJNNBV-IBGZPJMESA-N
gptkbp:hasMolecularFormula C22H17F2N5O3S
gptkbp:hasSMILES CC(C)C[C@@H](NC(=O)c1csc(n1)C2(F)CC2F)C3COC(C4=CC(=C(C=C4)Cl)Cl)N3Cn5cncn5
gptkbp:hasUNII P85L4UFQ8M
https://www.w3.org/2000/01/rdf-schema#label 242138-07-4
gptkbp:indication gptkb:mucormycosis
gptkb:invasive_aspergillosis
gptkbp:IUPACName N-[(2S)-1-[(2S)-2-(2,4-dichlorophenyl)-2-[(1H-1,2,4-triazol-1-yl)methyl]-1,3-dioxolan-4-yl]butan-2-yl]-4-(2,2-difluorocyclopropyl)-2-methyl-1,3-thiazole-5-carboxamide
gptkbp:KEGGID gptkb:D10366
gptkbp:legalStatus prescription only
gptkbp:marketedAs gptkb:Astellas_Pharma
gptkbp:molecularWeight 437.47 g/mol
gptkbp:otherName gptkb:Isavuconazole
gptkbp:PubChem_CID CHEMBL2108507
29385141
54767959
DB06619
gptkbp:routeOfAdministration oral
intravenous
gptkbp:usedAs antiviral drug
gptkbp:bfsParent gptkb:Xolair
gptkbp:bfsLayer 5